Giorgio Caravatti

This inventor holds 33 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Novartis Ag, Ciba-Geigy Corporation, Irm LLC. Active years: 1990-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giorgio Caravatti. Retrieved from https://idiyas.com/inventor/giorgio-caravatti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 6)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 10

Forward Citations = 401(Granted Patents)

Location History:

Allschwil, CH (1990 - 1998)
Basel, CH (2015)
Bottmingen, CH (2002 - 2017)

Company Filing History:

Ciba-Geigy Corporation

where one patent can have more than one assignee

Years Active: 1990-2017

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitors

Oxazolidin Compounds

Pyrrolidine Derivatives

Dihydro-Oxazine Derivatives

Bicyclic Amides

Cyclic Diaryl Ureas

Pyrrolo-Pyrimidines

Carbazole Derivatives

Hydrazones

Bipyridyls

Biaryl Compounds

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9763952 - Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives (2017-09-19),

2. 9539260 - Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives (2017-01-10),

3. 9458177 - Oxazolidin-2-one compounds and uses thereof (2016-10-04),

4. 8940771 - Organic compounds (2015-01-27),

5. 8865894 - Oxazolidin-2-one compounds and uses thereof (2014-10-21),

6. 8710085 - Pyrrolidine-1,2-dicarboxamide derivatives (2014-04-29),

7. 8552002 - Compounds and compositions as protein kinase inhibitors (2013-10-08),

8. 8476268 - Pyrrolidine-1,2-dicarboxamide derivatives (2013-07-02),

9. 8227462 - Pyrrolidine-1,2-dicarboxamide derivatives (2012-07-24),

10. 8026247 - Bicyclic amides as kinase inhibitors (2011-09-27),

11. 7855215 - Cyclic diaryl ureas suitable as tyrosine kinase inhibitors (2010-12-21),

12. 7691855 - Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives (2010-04-06),

13. 7625894 - Pyrrolo[2,3-d]Pyrimidines as Protein Tyrosine Kinase Inhibitors (2009-12-01),

14. 7390805 - 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives (2008-06-24),

15. 7329661 - N-phenyl-3-pyrimidine-amine derivatives (2008-02-12),

Title: Giorgio Caravatti - Pioneering Inventor from Bottmingen, CH

Introduction: Giorgio Caravatti is a renowned inventor hailing from Bottmingen, Switzerland, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Giorgio Caravatti's most recent patents include a revolutionary design for a sustainable energy generation system and a cutting-edge medical device aimed at improving patient care.

Career Highlights: Throughout his illustrious career, Giorgio Caravatti has been instrumental in developing innovative solutions for complex problems, earning him recognition as a trailblazer in the world of inventions. His work has significantly impacted industries such as renewable energy, healthcare, and technology.

Collaborations: Giorgio Caravatti has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His ability to work across disciplines and sectors has led to the successful implementation of several groundbreaking technologies.

Conclusion: Giorgio Caravatti's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring generations to come.

Profile summary based on public USPTO records.